![(4aS,5aS)-4,4a,5,5a-Tetrahydro-N-[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]-1-(4-oxido-2-pyraziny…](https://cymitquimica.com/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F299099-4as-5as-44a-55a-tetrahydro-n-1s-1-hydroxymethyl-22-dimethylpropyl-1-4-oxido-2-pyrazinyl-1h-cyclopropa-45-cyclopenta-12-c-pyrazole-3-carboxamide.webp&w=3840&q=75)
CAS 1268881-20-4
:(4aS,5aS)-4,4a,5,5a-Tetrahydro-N-[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]-1-(4-oxido-2-pyrazinyl)-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide
Description:
The chemical substance with the name "(4aS,5aS)-4,4a,5,5a-Tetrahydro-N-[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]-1-(4-oxido-2-pyrazinyl)-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide" and CAS number "1268881-20-4" is a complex organic compound characterized by its unique structural features, including a cyclopropane and pyrazole moiety. This compound exhibits chirality, indicated by the presence of specific stereocenters, which can influence its biological activity and interactions. The presence of functional groups such as carboxamide and hydroxymethyl suggests potential for hydrogen bonding and reactivity, making it of interest in medicinal chemistry. Its intricate structure may contribute to specific pharmacological properties, potentially impacting its efficacy and safety profile in therapeutic applications. Additionally, the compound's solubility, stability, and reactivity would be influenced by its molecular architecture, which is essential for understanding its behavior in biological systems and during synthesis. Overall, this substance represents a significant area of study in drug development and chemical research.
Formula:C18H23N5O3
InChI:InChI=1S/C18H23N5O3/c1-18(2,3)13(9-24)20-17(25)15-12-7-10-6-11(10)16(12)23(21-15)14-8-22(26)5-4-19-14/h4-5,8,10-11,13,24H,6-7,9H2,1-3H3,(H,20,25)/t10-,11-,13+/m0/s1
InChI key:InChIKey=ACSQLTBPYZSGBA-GMXVVIOVSA-N
SMILES:C(N[C@@H](C(C)(C)C)CO)(=O)C=1C2=C([C@@]3([C@@](C3)(C2)[H])[H])N(N1)C=4C=N(=O)C=CN4
Synonyms:- Olorinab
- (1aS,5aS)-2-(4-Oxy-pyrazin-2-yl)-1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid ((S)-1-hydroxymethyl-2,2-dimethyl-propyl)-amide
- (4aS,5aS)-4,4a,5,5a-Tetrahydro-N-[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]-1-(4-oxido-2-pyrazinyl)-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide
- 1H-Cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide, 4,4a,5,5a-tetrahydro-N-[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]-1-(4-oxido-2-pyrazinyl)-, (4aS,5aS)-
- APD 371
Sort by
Purity (%)
0
100
|
 0
|
 50
|
 90
|
 95
|
 100
Found 4 products.
- Ref: IN-DA01EAUC100mg703.00€250mgTo inquire500mgTo inquire
- Ref: 54-BUP015041mg81.00€5mg185.00€10mg272.00€25mg527.00€50mg783.00€
- APD 371CAS:A selective cannabinoid receptor type 2 (CB2) agonist. Commonly, CB2 agonists induce receptor internalization, which results in desensitization and tachyphylaxis. However, APD 371 mediates efficient recycling of internalized receptors back to the plasma membrane and thus sustains analgesic effects, upon subchronic treatment, in an osteoarthritis pain model in vivo.Formula:C18H23N5O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:357.41 g/mol- Ref: 3D-BA1651465mg203.00€10mg356.00€25mg637.00€50mg1,006.00€100mg1,516.00€
- OlorinabCAS:Olorinab (APD 371) (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist. With an EC50 of 6.2 nM for hCB2.Formula:C18H23N5O3Purity:97.67% - 98.47%Color and Shape:SolidMolecular weight:357.41









